Selecting Therapy for Steroid-Refractory Chronic GVHD
Dr Gooptu highlights how she selects therapy for a patient who is refractory to steroids for chronic GVHD and Dr Inyang notes the adverse events seen with these therapies.
Stay updated with breaking news from Agvhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Gooptu highlights how she selects therapy for a patient who is refractory to steroids for chronic GVHD and Dr Inyang notes the adverse events seen with these therapies.
The panel provides an overview of the frontline treatments available for chronic GVHD.
Dr Gooptu discusses the incidence of chronic GVHD and ruminates on how a patient’s medical history may impact their chronic GVHD risk.
Mahasweta Gooptu, MD shares insights on the early identification and diagnosis of chronic GVHD.
Researchers have found a new risk biomarker that can detect the early beginnings of graft-versus-host disease in new study.